广州禾信仪器股份有限公司 2024年年度股东大会会议材料 证券代码：688622 证券简称：禾信仪器 广州禾信仪器股份有限公司 2024年年度股东大会会议材料 二〇二五年四月 1 | 2024 年年度股东大会会议须知 | 4 | | --- | --- | | 2024 年年度股东大会会议议程 | 7 | | 2024 年年度股东大会会议议案 | 11 | | 关于 2024 年度董事会工作报告的议案 | 12 | | 关于 2024 年度监事会工作报告的议案 | 13 | | 关于 2024 年度财务决算报告的议案 | 14 | | 关于 2025 年度财务预算报告的议案 | 15 | | 关于 2024 年年度报告及其摘要的议案 | 16 | | 关于 2024 年年度利润分配方案的议案 | 17 | | 关于续聘 2025 年度会计师事务所的议案 | 18 | | 关于公司董事 2025 年度薪酬方案的议案 | 19 | | 关于公司监事 2025 年度薪酬方案的议案 | 21 | | 关于公司符合发行股份及支付现金购买资产并募集配套资金暨关联交易有关条件的议 | | | 案 | 23 | | 关于公司 ...

导读： 公司实现营业收入2.03亿元，同比下降44.70%；归属净利润亏损4599.09万元，已连续三年亏损，累计亏损金额超过2亿元。 特别提示 微信公众号机制调整，请点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 禾信仪器2 0 2 4年财报显示，公司实现营业收入2 . 0 3亿元，同比下降4 4 . 7 0%；归属净利润亏损4 5 9 9 . 0 9万元，已连续三年亏损，累计亏损金额超 过2亿元。 数据显示，公司员工规模从2 0 2 3年的6 8 4人缩减至2 7 6人，其中研发人员减少1 0 2人。报告期内研发投入金额为3 2 8 0 . 5 9万元，同比 下降5 1 . 4 4%，研发投入占营收比例降至1 6 . 2 0%。此外，公司毛利率自2 0 2 1年的5 1 . 6 7%持续下滑至2 0 2 4年的3 6 . 5 0%。 | | | | | 单位:元 币种:人民币 | | --- | --- | --- | --- | --- | | 主要会计数据 | 2024年 | 2023年 | 本期比上 年同期增 | 2022年 | | | | | 減(%) ...

广发证券股份有限公司 关于广州禾信仪器股份有限公司 2024 年度持续督导跟踪报告 根据《证券发行上市保荐业务管理办法》《上海证券交易所科创板股票上市 规则》等有关法律、法规的规定，广发证券股份有限公司（以下简称"广发证券"、 "保荐机构"）作为广州禾信仪器股份有限公司（以下简称"禾信仪器"、"公 司"）2024 年度的持续督导机构，负责禾信仪器 2024 年度的持续督导工作，并 出具本年度持续督导跟踪报告。 2024 年度，广发证券对禾信仪器的持续督导工作情况总结如下： | 序号 | 工作内容 | 实施情况 | | --- | --- | --- | | | 建立健全并有效执行持续督导工作制度，并针 | 保荐机构已建立健全并有效执行了 | | 1 | 对具体的持续督导工作制定相应的工作计划。 | 持续督导制度，已制定了相应的工 | | | | 作计划。 | | | 根据中国证监会相关规定，在持续督导工作开 | 保荐机构已与禾信仪器签订《保荐 | | | 始前，与上市公司或相关当事人签署持续督导 | 协议》，该协议已明确了双方在持 | | 2 | 协议，明确双方在持续督导期间的权利义务， | 续督导期间的权利 ...

广发证券股份有限公司 关于广州禾信仪器股份有限公司 首次公开发行股票并上市 之持续督导保荐总结报告书 2021 年 9 月，广州禾信仪器股份有限公司（以下简称"禾信仪器"、"公 司"）首次公开发行股票并在科创板上市，国信证券股份有限公司（以下简称"国 信证券"）担任保荐机构并负责禾信仪器上市后的持续督导工作，持续督导期至 2024 年 12 月 31 日止。2023 年 2 月，公司聘请广发证券股份有限公司（以下简 称"广发证券"、"保荐机构"）担任向不特定对象发行可转换公司债券的保荐 机构，根据中国证监会《证券发行上市保荐业务管理办法》等相关规定，公司已 于 2023 年 2 月与广发证券签署保荐协议，自签署保荐协议之日起，国信证券尚 未完成的持续督导工作将由广发证券承接，由广发证券承接自协议生效之日起至 2024 年 12 月 31 日止的首次公开发行股票持续督导工作，并按照相关法律、法 规和交易规则的规定履行持续督导义务，承担法律责任。目前，禾信仪器首次公 开发行股票并上市的持续督导期限已届满，广发证券现根据相关规定出具本持续 督导保荐总结报告书。 一、保荐机构及保荐代表人承诺 1、保荐总结报告书和证明 ...

Core Viewpoint - HeXin Instruments, known as the "first stock in mass spectrometry," reported a significant decline in revenue and continued losses, raising questions about its long-term stability and ability to navigate through industry challenges [1][2]. Financial Performance - In 2024, HeXin Instruments achieved revenue of 203 million yuan, a year-on-year decrease of 44.7%, and a net profit attributable to shareholders of -45.99 million yuan, although the loss margin has narrowed [1][2]. - The company has experienced three consecutive years of losses since 2022, with revenues of 280 million yuan in 2022, 366 million yuan in 2023, and 203 million yuan in 2024, alongside net losses of -63.33 million yuan, -96.11 million yuan, and -45.99 million yuan respectively [2]. Business Strategy and Adjustments - In response to market changes, HeXin Instruments adjusted its sales strategy in 2024, focusing on key provinces and important markets while promoting star products and potential offerings [3]. - The company aims to reduce reliance on government procurement in the environmental monitoring sector and is actively pursuing technological breakthroughs and product layouts in medical and laboratory fields [3][8]. Workforce and Cost Management - HeXin Instruments underwent significant layoffs, reducing its workforce from 684 in 2023 to 276 in 2024, including a sharp decrease in R&D personnel from 102 to 43 [6]. - The total salary for R&D staff decreased by 60.96%, while the average salary increased from 321,800 yuan in 2023 to 423,600 yuan in 2024 [6][7]. Research and Development - R&D expenses decreased by 51.44% to 32.81 million yuan in 2024, as the company streamlined its resource allocation after achieving a comprehensive technology roadmap and product line [7]. - The mass spectrometry industry is characterized by high value-added and technology-intensive features, with significant barriers to entry due to the dominance of foreign manufacturers in the market [7][8]. Market Position and Competition - HeXin Instruments has established an industry advantage in environmental monitoring but faces intense competition and pressure reflected in its financial performance [8]. - The company is also competing with domestic manufacturers that are increasingly launching mass spectrometry products and enhancing R&D investments under government encouragement for domestic substitution [8].

2025年4月3日，科创板"国产质谱仪龙头" 禾信仪器 (688622)股价定格在97.52元，总市值68.26亿元—— 较2021年上市首日240亿元的巅峰市值已蒸发超七成。这家曾被寄予"打破国外垄断"厚望的高科技企 业，正陷入"越亏越扩产，越扩产越亏损"的死亡循环。 财报显示，公司2024年净亏损4599万元，虽同比收窄52%，但已连续三年累计亏损2.5亿元。更严峻的 是，营收同比腰斩至2.03亿元，经营活动现金流仅-821万元，应收账款高达1.08亿元，占营收的53%。 这种"有收入无现金"的畸形模式，暴露出商业模式的致命缺陷。 尽管业绩惨淡，禾信仪器仍维持68亿元市值，市销率高达33.6倍，远超行业平均水平。这种"市梦率"背 后，是量子计算概念的疯狂炒作。2024年10月重组停牌期间，公司股吧出现大量"量子黑马""国产算力 新龙头"等煽动性言论，复牌后股价一度涨停。 但清醒的投资者已用脚投票：前十大股东中，社保基金、公募基金等机构持股比例从2023年的18%降至 2024年的9%。更讽刺的是，公司实控人周振在2024年质押了56%的股份，折射出对未来的极度不自 信。 编辑有话说 禾信仪器作为一家曾经的 ...

中国经济网北京4月7日讯禾信仪器(688622.SH)近日发布的2024年年度报告显示，2024年公司实现营业 收入2.03亿元，同比下降44.70%；实现归属于上市公司股东的净利润-4599.09万元，上年同期为-9610.61 万元；实现归属于上市公司股东的扣除非经常性损益的净利润-6309.96万元，上年同期为-1.11亿元；经 营活动产生的现金流量净额-821.32万元，去年同期为-3636.73万元。 | | | | | 甲位: 兀 巾秤:人民巾 | | --- | --- | --- | --- | --- | | 主要会计数据 | 2024年 | 2023年 | 本期比上 年同期增 | 2022年 | | | | | 减(%) | | | 营业收入 | 202, 509, 098. 56 | 366, 178, 970. 23 | -44.70 | 280. 256. 751. 73 | | 扣除与主营业务无 关的业务收入和不 具备商业实质的收 | 198, 015, 471. 59 | 361,648,041,28 | -45.25 | 276, 542, 545. 41 | | 入后的营业收 ...

Market News - The National Bureau of Statistics will release March CPI and PPI data on April 10, with February figures showing a month-on-month CPI decrease of 0.2% and a year-on-year decrease of 0.7%, while PPI decreased by 0.1% month-on-month and 2.2% year-on-year [2] - The People's Bank of China has 763.4 billion yuan in reverse repos and 150 billion yuan in treasury cash deposits maturing this week, with specific amounts maturing each day [3] - The U.S. will release March CPI data on April 10, which is expected to be a significant test for the dollar, as persistent inflation could support the dollar and raise concerns about further interest rate cuts by the Federal Reserve [4] Sector Events - The 10th China Science and Technology Finance Forum will be held in Beijing on April 7, focusing on summarizing reform achievements and innovative paths for the future of technology finance [6] - The 2025 Global 6G Technology and Industry Ecosystem Conference will take place in Nanjing from April 10 to 12, gathering global leaders in the 6G field to discuss innovation and future industry development [7] - The Ministry of Commerce has announced export controls on seven categories of medium and heavy rare earths, effective immediately, to safeguard national security and fulfill international obligations [8] - Amazon plans to launch its first batch of 27 satellites for its Project Kuiper on April 9, entering competition with SpaceX's Starlink [9] Company News - HeXin Instruments plans to acquire a 56% stake in Shanghai Liangxi Technology Co., Ltd. through a combination of share issuance and cash payment [11] - Shengnong Development intends to acquire a 54% stake in Anhui Sun Valley Food Technology Group for 1.126 billion yuan, enhancing its integrated industry chain [12] - Lier Chemical expects a net profit of 145 to 155 million yuan for Q1 2025, representing a year-on-year increase of 203.08% to 223.98% due to rising sales and prices [13] - Stone Technology reported a revenue of 11.945 billion yuan for 2024, a year-on-year increase of 38.03%, and a net profit of 1.977 billion yuan, a decrease of 3.64% [14] - Chengdi Xiangjiang announced a contract worth 4.452 billion yuan for a data center project with China Mobile, with a cooperation period of seven years plus an uncertain duration [15] Restricted Shares - This week, 24 companies in the A-share market will have a total of 1.735 billion shares released from restrictions, with a total market value of 35.015 billion yuan, an increase of 12.411 billion yuan week-on-week [17] New Stock Calendar - Two new stocks are set to be issued this week, with a total of approximately 42.6 million shares and expected fundraising of 1.161 billion yuan [21] Market Outlook - Dongfang Securities suggests the market may see a turning point post-holiday, with potential for a rebound as policy benefits are released in Q2 [24] - Founder Securities believes A-shares may perform better than global markets due to positive macro policies and recovering domestic demand [25] - Dongguan Securities anticipates a range-bound market in the short term due to global volatility and upcoming earnings reports [26] - Guojin Securities recommends a shift in investment strategy towards large-cap value stocks, focusing on "profit bottom" logic in the upcoming quarter [27]

附件2 注1："质谱产业化基地扩建项目"达产后，公司根据经济环境变化、订单情况及库存情况适时调整了生 产经营及市场推广策略，导致公司达成期后产量情况及产能利用率结果无法真实反映公司实际经营情 况，具体为：1）公司优化了生产计划管理模式，从以往基于预测的备货管理模式向订单排产为主的计 划管理模式转变，大力推动库存去化工作，导致达产期后生产需求减少；2）公司根据市场销售情况调 整了DEMO机市场投放方式，收回部分DEMO机并转销售，减缓了生产需求。 注2："质谱产业化基地扩建项目"实现效益的计算口径、计算方法与承诺效益的计算口径、计算方法一 致。由于公司在募投项目建成后将原产能整体搬迁至质谱产业化基地，原产能与募投项目新增产能已无 法明显区分，故实现效益按照募投项目承诺生产的仪器（包括SPA系列、SPI系列、AC-GCMS系列、 CMI系列、LC-TQ系列、GGT系列）以报告期内实现的利润进行测算。公司经营业绩由于行业竞争加 剧、经营战略调整、营业收入下滑等原因仍处于亏损状态，故该项目尚未达到预计效益。 注3："综合服务体系建设项目"实现效益的计算口径、计算方法与承诺效益的计算口径、计算方法一 致。由于公司综合服 ...

Group 1 - The company plans to acquire Shanghai Liangxi Technology Co., Ltd. through a combination of issuing shares and cash payment to two counterparties, Wu Ming and Shanghai Yandao Enterprise Management Partnership (Limited Partnership) [1] - The pricing for the share issuance is set at 17.60 yuan per share, with a total transaction value of 383.60 million yuan, of which 246.40 million yuan will be paid in shares, resulting in the issuance of 14 million shares [2] - The controlling shareholder and actual controller of the company, Mr. Zhou Zhen, will remain unchanged before and after the transaction, ensuring no change in control of the company [2] Group 2 - After the transaction, Wu Ming will become a shareholder holding more than 5% of the company's shares [2] - The transaction is subject to approval by the company's shareholders' meeting and relevant regulatory authorities, indicating uncertainty regarding its implementation [3]